Compare AORT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | AZTA |
|---|---|---|
| Founded | 1984 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1996 | 1996 |
| Metric | AORT | AZTA |
|---|---|---|
| Price | $23.15 | $34.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $49.40 | $40.60 |
| AVG Volume (30 Days) | 532.5K | ★ 686.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.62 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $298,836,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $14.20 | $6.99 |
| Revenue Next Year | $11.20 | $5.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $19.16 | $15.93 |
| 52 Week High | $48.25 | $41.73 |
| Indicator | AORT | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.50 | 61.50 |
| Support Level | $22.83 | $33.39 |
| Resistance Level | $25.04 | $37.49 |
| Average True Range (ATR) | 0.95 | 1.05 |
| MACD | -0.20 | 0.16 |
| Stochastic Oscillator | 11.58 | 87.02 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.